ESHAP for primary cutaneous T-cell lymphomas: efficacy and tolerance in 11 patients.
Mebazaa A, Dupuy A, Rybojad M, Mouly F, Moulonguet I, Vignon-Pennamen MD, Rivet J, Janin A, Lebbé C, Dubertret L, Morel P, Bachelez H, Brice P.
Mebazaa A, et al.
Hematol J. 2005;5(7):553-8. doi: 10.1038/sj.thj.6200570.
Hematol J. 2005.
PMID: 15692599